SI9111508B - Recombinant DNA and RNA and products derived therefrom - Google Patents

Recombinant DNA and RNA and products derived therefrom Download PDF

Info

Publication number
SI9111508B
SI9111508B SI9111508A SI9111508A SI9111508B SI 9111508 B SI9111508 B SI 9111508B SI 9111508 A SI9111508 A SI 9111508A SI 9111508 A SI9111508 A SI 9111508A SI 9111508 B SI9111508 B SI 9111508B
Authority
SI
Slovenia
Prior art keywords
cav
nucleotide sequence
nucleic acid
recombinant nucleic
specific
Prior art date
Application number
SI9111508A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9111508A (sl
Inventor
Mathieu Hubertus Maria Noteborn
Gerben Foppe De Boer
Original Assignee
Aesculaap Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aesculaap Bv filed Critical Aesculaap Bv
Publication of SI9111508A publication Critical patent/SI9111508A/sl
Publication of SI9111508B publication Critical patent/SI9111508B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
SI9111508A 1990-09-12 1991-09-11 Recombinant DNA and RNA and products derived therefrom SI9111508B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.
YU150891A YU49095B (sh) 1990-09-12 1991-09-11 Rekombinantna dnk i rnk i proizvodi dobijeni od njih

Publications (2)

Publication Number Publication Date
SI9111508A SI9111508A (sl) 1998-10-31
SI9111508B true SI9111508B (en) 2001-12-31

Family

ID=19857669

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9111508A SI9111508B (en) 1990-09-12 1991-09-11 Recombinant DNA and RNA and products derived therefrom

Country Status (21)

Country Link
US (6) US5491073A (de)
EP (2) EP0905246A1 (de)
JP (1) JP2846116B2 (de)
AT (1) ATE188739T1 (de)
AU (1) AU651999B2 (de)
CA (1) CA2091181C (de)
DE (1) DE69131903T2 (de)
DK (1) DK0548234T3 (de)
ES (1) ES2144399T3 (de)
GR (1) GR3033173T3 (de)
HR (1) HRP940668B1 (de)
HU (1) HU220102B (de)
IL (1) IL99435A (de)
MX (1) MX9101042A (de)
NL (1) NL9002008A (de)
RU (1) RU2146292C1 (de)
SI (1) SI9111508B (de)
UA (1) UA48936C2 (de)
WO (1) WO1992004446A1 (de)
YU (1) YU49095B (de)
ZA (1) ZA917065B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
US20020061296A1 (en) * 2000-09-08 2002-05-23 Noteborn Mathieu H.M. Delivery method for the tumor specific apoptosis inducing activity of apoptin
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
US5922600A (en) * 1990-09-12 1999-07-13 Leadd Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
CA2221570A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Neutralizing conformation epitopes of chicken anemia virus
US6127115A (en) * 1995-11-14 2000-10-03 Ragland; William L. Efficient method of detecting an infectious agent in blood
AU756587B2 (en) 1997-08-12 2003-01-16 Leadd B.V. Determining the transforming capability of agents
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
DK1083224T3 (da) * 1999-09-02 2007-04-10 Leadd Bv Apoptin-associerende protein
CA2393859A1 (en) * 1999-12-10 2001-06-14 Leadd B.V. Apoptin-associating protein
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
CN100589746C (zh) * 2000-07-10 2010-02-17 尤妮佳股份有限公司 清扫物品
EP1199363A1 (de) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylationsmodifikationen von Apoptin
US20050169939A1 (en) * 2001-09-05 2005-08-04 Leonard Joan D. Chicken anemia virus vaccine from cell line
US7566548B2 (en) * 2004-08-13 2009-07-28 University Of Massachusetts Methods for identifying therapeutic agents and for treating disease
CN102636646A (zh) * 2012-05-15 2012-08-15 扬州大学 快速检测禽白血病抗原的试纸条及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS6032714A (ja) 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
DE3583799D1 (de) 1985-01-11 1991-09-19 Abbott Lab Ltd Feste zubereitung mit langsamer freisetzung.
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5079005A (en) 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
JP3292371B2 (ja) * 1988-09-13 2002-06-17 メリアル ウイルスのヌクレオチド配列
GB2237510B (en) 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic

Also Published As

Publication number Publication date
WO1992004446A1 (en) 1992-03-19
IL99435A (en) 2006-10-31
ES2144399T3 (es) 2000-06-16
ATE188739T1 (de) 2000-01-15
US6509446B2 (en) 2003-01-21
HUT65974A (en) 1994-08-29
ZA917065B (en) 1992-05-27
AU8658091A (en) 1992-03-30
DK0548234T3 (da) 2000-06-19
EP0905246A1 (de) 1999-03-31
YU49095B (sh) 2003-12-31
US5491073A (en) 1996-02-13
UA48936C2 (uk) 2002-09-16
JPH06504195A (ja) 1994-05-19
US5932476A (en) 1999-08-03
CA2091181A1 (en) 1992-03-13
YU150891A (sh) 1995-10-24
IL99435A0 (en) 1992-08-18
HRP940668A2 (en) 1997-12-31
US5958424A (en) 1999-09-28
DE69131903D1 (de) 2000-02-17
HRP940668B1 (en) 2000-10-31
DE69131903T2 (de) 2000-07-20
NL9002008A (nl) 1992-04-01
EP0548234B1 (de) 2000-01-12
HU220102B (hu) 2001-10-28
JP2846116B2 (ja) 1999-01-13
RU2146292C1 (ru) 2000-03-10
CA2091181C (en) 2006-02-21
GR3033173T3 (en) 2000-08-31
SI9111508A (sl) 1998-10-31
US6319693B1 (en) 2001-11-20
MX9101042A (es) 1992-08-10
US6238669B1 (en) 2001-05-29
HU9300716D0 (en) 1993-06-28
US20020103336A1 (en) 2002-08-01
AU651999B2 (en) 1994-08-11
EP0548234A1 (de) 1993-06-30

Similar Documents

Publication Publication Date Title
SI9111508B (en) Recombinant DNA and RNA and products derived therefrom
Neiman Measurement of endogenous leukosis virus nucleotide sequences in the DNA of normal avian embryos by RNA-DNA hybridization
US10655173B2 (en) Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing
Zoller et al. [32] Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors
Bishop et al. Purification and characterization of poliovirus-induced infectious double-stranded ribonucleic acid
CA1296242C (en) Competitive homogeneous assay
Walberg et al. In vitro transcription of human mitochondrial DNA. Identification of specific light strand transcripts from the displacement loop region.
Reeves et al. Genomic transcriptional activity and the structure of chromatin
Brack et al. DNA Electron Microscopy-Part I
CN110312800A (zh) 处理核酸样本的方法
Smith et al. Analysis of rna initiated in isolated mouse myeloma nuclei using purine nucleoside 5′[γ-S] triphosphates as affinity probes
CN113215167B (zh) 核酸适配体及其在检测大口黑鲈虹彩病毒感染的细胞中的应用
Harada et al. Series of 4.5 S RNAs associated with poly (A)-containing RNAs of rodent cells
Flint et al. Characterization of single-stranded viral DNA sequences present during replication of adenovirus types 2 and 5
CN112458198B (zh) 抗褐飞虱基因Bph27的辅助育种分子标记及其应用
CN108220399A (zh) 一种基于通用探针技术的荧光定量pcr方法
Toriyama et al. Characterization of single-and double-stranded RNAs in particles of rice stripe virus
Bienstock et al. Structural and functional characterization of the human DNA repair helicase XPD by comparative molecular modeling and site-directed mutagenesis of the bacterial repair protein UvrB
Ito et al. Temperature-sensitive mutants of reovirus: II. Anomalous electrophoretic migration of certain hybrid RNA molecules composed of mutant plus strands and wild-type minus strands
EP0128018A2 (de) Molekulare genetische Sonde und Verfahren zu ihrer Herstellung, Testmethode und Satz in denen diese molekulare genetische Sonde gebraucht wird
Badaracco et al. Purification and characterization of yeast topoisomerase I.
Hentschel et al. Transcriptional fidelity of histone genes injected into Xenopus oocyte nuclei
Strauss et al. Variables affecting the selectivity and efficiency of retention of DNA fragments by E. coli RNA polymerase in the nitrocellulose-filter-binding assay
EP1041160A1 (de) Verfahren zur detektion einer mutation innerhalb einer basensequenz
Alwine et al. A small RNA induced late in simian virus 40 infection can associate with early viral mRNAs.

Legal Events

Date Code Title Description
IF Valid on the event date